The Republican health care plan, which would roll back the Affordable Care Act and reduce or terminate health coverage for millions of Americans, will deepen the nation’s opioid crisis, addiction experts tell the Los Angeles Times.
“It would essentially write off a generation,” said Dr. Shawn Ryan, President of BrightView Health, a network of drug treatment clinics in Cincinnati. “It would be catastrophic.”
Full story of Republican health care plan and opioid crisis at drugfree.org
The total cost of heroin use in the United States reached more than $51 billion in 2015, according to a new study by researchers at the University of Illinois at Chicago.
The cost estimate includes heroin-related crime and imprisonment, as well as addiction treatment and chronic infectious diseases contracted through heroin use, such as HIV, tuberculosis and hepatitis B and C, HealthDay reports. Other costs include treating newborns with heroin-related medical conditions, overdose deaths and lost productivity on the job.
Full story of cost of heroin use in the United States at drugfree.org
Electrical engineers are creating a wearable sensor to help people manage their alcohol intake.
Activity trackers monitor your steps; this innovative sensor measures your blood alcohol level. Worn like a watch, this sensor picks up vapors from the skin and sends the data to a server. If the alcohol reading is high, via an app, a designated loved one gets an alert to check in on the user. This easy-to-wear gadget will help address issues with social drinking and addiction.
“We wanted to create an unobtrusive sensor that would be easy to wear, and help people struggling with alcohol,” said the inventor, Shekhar Bhansali, an Alcatel Lucent professor and chair of the Department of Electrical and Computer Engineering. “This is one step toward active intervention that only requires the user wear the sensor.”
Full story of wearable sensors to manage alcohol intake at Science Daily
A new study published today by the scientific journal Addiction reveals that the incidence of neonatal abstinence syndrome — often caused by mothers using opioids during pregnancy — is increasing in the United States, and carries an enormous burden in terms of hospital days and costs. The number of US hospital admissions involving neonatal abstinence syndrome increased more than fourfold between the years 2003 and 2012. In 2012, neonatal abstinence syndrome cost nearly $316 million in the United States.
Neonatal abstinence syndrome (NAS) is a constellation of symptoms that occur in newborn infants exposed to addictive illegal or prescription drugs in utero. Infants affected by NAS typically show a number of neurological symptoms and behaviors (e.g., tremors, seizures) as well as poor feeding and gastrointestinal dysfunction. Standard management of NAS involves the administration of opioids for opioid withdrawal, with additional medications for stubborn cases or instances of multi-drug exposure. This drug administration has been performed traditionally in the hospital setting, consuming valuable and finite hospital resources.
Full story of opioid use during pregnancy at Science Daily
The regulatory approaches to marijuana and tobacco in the United States are on decidedly different paths and, according to researchers from the U.S. and Australia, neither side appears interested in learning from the other.
“The two policy communities have shown very little interest in each other’s policy debates,” Wayne Hall and Lynn Kozlowski write in a new paper published in the journal Addiction.
Hall, the lead author, is a professor at the Centre for Youth Substance Abuse Research at the University of Queensland, Australia, and is an expert on marijuana and other drug use issues. Kozlowski is professor of community health and health behavior in the University at Buffalo’s School of Public Health and Health Professions and an expert on tobacco use and control.
Full story of marijuana and tobacco policy camps at Science Daily